Infectious Diseases – News and Features

Researchers reports that increasing a specific protein in areas of the pancreas that produce insulin blocks the immune attack that causes type 1 diabetes.

The treatment phase in Phase 2 dose-ranging clinical trial of 169 hepatitis C patients has been completed.

This article is the first report on reference gene selection in virus-infected insects demonstrating how this might serve as a precedent for future gene expression studies on MRCV and other virus-planthopper pathosystems.

In this article, researchers from Freie Universität of Berlin compile the general physiological aspects of the infection along with new research updates on nanocarriers used in prevention of tuberculosis.

Scientists are part of an international consortium that has successfully sequenced and analyzed the potato genome.

Phase II trial in severe sepsis demonstrates the activity and tolerability of talactoferrin.

This article details how researchers from The University of Birmingham have combined molecular and phenotypic analysis of wild-type and mutant strains with computational network inference to identify molecular pathways underlying E. coli response to mild and strong acid conditions.

The research group conduct a genome-wide study to identify risk factors connecting HVC and HCC.

Mass spectrometry accelerates research to identify microbiological sources of E. coli-related illnesses and diseases.

Researchers from the University of Liverpool and the London and Liverpool Schools of Tropical Medicine have developed a new series of tetraoxane analogues and screened them for their in vitro and in vivo antimalarial activity.